Bausch Health Companies Inc (BVF MU) stock market data APIs
€5.5111
0(0%)
as of July 18, 2025
Try our APIs with
free plan!
Bausch Health Companies Inc Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for BVF.MU.
Prev. Close
5.5111
Open
5.5111
High
5.5111
Low
5.5111
52 wk Range
3.8885-9.127
Market Cap
7 764 M
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Bausch Health Companies Inc data using free add-ons & libraries
Get Bausch Health Companies Inc Fundamental Data
Bausch Health Companies Inc Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Bausch Health Companies Inc News
New
Bausch Health's Xifaxan Patent Clarity, Policy Commentary in Focus for Q2, RBC Says
Bausch Health's (BHC) potential updates on the patent infringement case regarding the Xifaxan drug a PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscri...
Bausch Health Companies (BHC) Canada Announces Expanded Availability of CABTREO Gel
Bausch Health Companies Inc. (NYSE:BHC) is one of the 13 Best Healthcare Stocks to Buy Under $10. On July 9, Bausch Health Companies Inc. (NYSE:BHC), Canada, announced the availability of CABTREO gel ...
Chlamydia Market Analysis and Forecast, 2025-2035 Featuring ActivBiotics, Bausch Health, Allergan, WCG Clinical, Hologic, Evofem, CRMI, Meridian Bioscience, Pfizer
Company Logo The global chlamydia market is projected for significant growth driven by rising chlamydia infections, with 127 million new cases annually, as per the World Health Organization. Key fact...
CORRECTING and REPLACING: Bausch Health, Canada Inc. Treatment for Acne Vulgaris, (Pr)CABTREO(TM) (clindamycin phosphate, adapalene and benzoyl peroxide gel), Now Available Through Public Drug Plans of Ontario, Nova Scotia and Two Federal Programs
This press release updates the headline of the previously posted release LAVAL, QC / ACCESS Newswire / July 10, 2025 / Bausch Health, Canada Inc., part of Bausch Health Companies Inc. (NYSE:BHC)(TSX:...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
